跳至主要内容
临床试验/NCT00188877
NCT00188877已完成2 期

A Phase II Study of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2003年6月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
44
试验地点
2
主要终点
The primary objective of this study is to evaluate 3 year local progression free survival in patients with nasopharyngeal carcinoma treated with Intensity Modulated Radiation Therapy (IMRT) techniques.

研究概览

简要总结

Many normal tissues, including the eyes, brain, and spinal cord are very close to cancers in the nasopharynx. The dose of radiation delivered to the cancer is limited by tolerance of these normal tissues. Standard radiation treatment techniques using three or four radiation beams cannot avoid delivering some dose of radiation to these normal tissues that do not need to get radiation. Intensity Modulated Radiation Therapy (IMRT) uses many hundreds of computer-controlled radiation beams aimed at your cancer to try to lower the amount of radiation that normal tissues receive, while still delivering the desired amount of radiation to your cancer and to areas that your doctor thinks may have cancer cells.

The doctors at Princess Margaret Hospital are conducting this study in order to test whether the use of IMRT techniques can improve the chance of controlling your cancer in the head and neck region.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed histopathologic diagnosis of nasopharyngeal squamous cell carcinoma requiring primary radiation
  • less than 70 yrs of age
  • Stage T1-T4; N0-N3; M0
  • KPS less than 70
  • no prior RT to H&N or chemotherapy for H&N
  • no other malignancy except non-melanomatous skin cancer
  • no distant mets
  • no contraindication to RT or chemotherapy
  • adequate organ function
  • informed consent
  • Exclusion Criteria
  • Major medical or psychiatric illness, which would interfere with either completion of therapy and follow-up or with full and complete understanding of the risks and potential complications of the therapy.

排除标准

  • 未提供

结局指标

主要结局

The primary objective of this study is to evaluate 3 year local progression free survival in patients with nasopharyngeal carcinoma treated with Intensity Modulated Radiation Therapy (IMRT) techniques.

时间窗: q2 monthly during year 1, q3 monthly during year 2; q4 monthly during year 3; q6 monthly during year 4 and annually thereafter

次要结局

  • -the ability of IMRT techniques to spare long term xerostomia as evaluated by saliva flow rates.
  • -the nature and prevalence of acute and late side effects and their relationship to local dose.
  • -the dosimetric differences between conventional "forward planned" two dimensional plans, three dimensional plans and Intensity modulated radiation therapy.
  • -evaluation of failure with respect to the doses in the region of the failure
  • -quality of life measurements in patients after receiving IMRT for the treatment of nasopharyngeal carcinoma

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验